tiprankstipranks
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market
2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2315 full AI Analyst Report?

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Ratios

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Ratios

HK:2315's free cash flow for Q4 2025 was ¥0.74. For the 2025 fiscal year, HK:2315's free cash flow was decreased by ¥ and operating cash flow was ¥0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.31 2.31 1.53 1.25 1.52
Quick Ratio
 2.12 2.12 1.33 1.23 1.36
Cash Ratio
 1.68 1.68 0.71 0.69 1.00
Solvency Ratio
 0.22 0.22 0.13 -0.12 -0.28
Operating Cash Flow Ratio
 0.39 0.40 0.39 -0.13 -0.50
Short-Term Operating Cash Flow Coverage
 1.86 1.89 1.01 -0.43 -2.39
Net Current Asset Value
¥ 603.86M¥ 603.86M¥ -760.18M¥ -935.92M¥ -729.72M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.16 0.24 0.22 0.15
Debt-to-Equity Ratio
 0.27 0.27 0.68 0.69 0.36
Debt-to-Capital Ratio
 0.21 0.21 0.41 0.41 0.27
Long-Term Debt-to-Capital Ratio
 0.08 0.08 0.19 0.18 0.04
Financial Leverage Ratio
 1.71 1.71 2.90 3.12 2.44
Debt Service Coverage Ratio
 1.52 1.52 0.98 -0.36 -2.55
Interest Coverage Ratio
 3.92 3.92 1.79 -2.71 -9.45
Debt to Market Cap
 0.02 0.03 0.13 0.09 0.02
Interest Debt Per Share
 1.64 1.64 1.66 1.62 1.20
Net Debt to EBITDA
 -2.33 -2.33 0.62 -1.48 0.40
Profitability Margins
Gross Profit Margin
75.83%75.83%77.67%70.59%73.38%
EBIT Margin
18.79%18.79%13.73%-39.10%-113.25%
EBITDA Margin
30.42%30.42%30.99%-13.65%-87.26%
Operating Profit Margin
20.21%20.21%16.76%-37.70%-99.36%
Pretax Profit Margin
13.64%13.64%4.38%-53.03%-112.64%
Net Profit Margin
12.56%12.56%3.42%-53.42%-112.79%
Continuous Operations Profit Margin
12.56%12.56%3.42%-53.42%-112.79%
Net Income Per EBT
92.11%92.11%78.11%100.74%100.13%
EBT Per EBIT
67.49%67.49%26.12%140.65%113.37%
Return on Assets (ROA)
4.65%4.65%1.39%-15.63%-21.51%
Return on Equity (ROE)
11.29%7.96%4.02%-48.73%-52.53%
Return on Capital Employed (ROCE)
9.97%9.97%8.74%-14.44%-24.18%
Return on Invested Capital (ROIC)
8.49%8.49%6.09%-13.03%-22.43%
Return on Tangible Assets
4.67%4.67%1.40%-15.82%-21.74%
Earnings Yield
0.98%1.37%1.06%-9.42%-6.77%
Efficiency Ratios
Receivables Turnover
 4.39 4.39 4.18 5.01 4.96
Payables Turnover
 2.45 2.45 1.90 1.20 0.97
Inventory Turnover
 1.91 1.91 2.11 21.31 1.49
Fixed Asset Turnover
 1.01 1.01 0.73 0.49 0.33
Asset Turnover
 0.37 0.37 0.41 0.29 0.19
Working Capital Turnover Ratio
 1.68 1.84 4.59 3.13 1.44
Cash Conversion Cycle
 125.68 125.68 67.39 -213.36 -57.58
Days of Sales Outstanding
 83.05 83.05 87.26 72.82 73.62
Days of Inventory Outstanding
 191.42 191.42 172.65 17.13 244.23
Days of Payables Outstanding
 148.79 148.79 192.52 303.31 375.42
Operating Cycle
 274.47 274.47 259.91 89.95 317.85
Cash Flow Ratios
Operating Cash Flow Per Share
 0.91 0.93 0.53 -0.19 -0.77
Free Cash Flow Per Share
 0.71 0.71 0.44 -0.51 -1.39
CapEx Per Share
 0.22 0.22 0.09 0.32 0.61
Free Cash Flow to Operating Cash Flow
 0.78 0.76 0.82 2.65 1.79
Dividend Paid and CapEx Coverage Ratio
 4.15 4.22 5.69 -0.61 -1.26
Capital Expenditure Coverage Ratio
 4.15 4.22 5.69 -0.61 -1.26
Operating Cash Flow Coverage Ratio
 0.62 0.63 0.37 -0.14 -0.73
Operating Cash Flow to Sales Ratio
 0.26 0.27 0.22 -0.11 -0.57
Free Cash Flow Yield
1.58%2.23%5.48%-5.00%-6.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 101.43 73.24 94.73 -10.61 -14.77
Price-to-Sales (P/S) Ratio
 12.92 9.20 3.24 5.67 16.66
Price-to-Book (P/B) Ratio
 8.08 5.83 3.81 5.17 7.76
Price-to-Free Cash Flow (P/FCF) Ratio
 63.05 44.91 18.25 -19.99 -16.35
Price-to-Operating Cash Flow Ratio
 48.26 34.26 15.04 -53.02 -29.33
Price-to-Earnings Growth (PEG) Ratio
 0.28 0.18 -0.87 0.28 -1.36
Price-to-Fair Value
 8.08 5.83 3.81 5.17 7.76
Enterprise Value Multiple
 40.12 27.91 11.08 -43.00 -18.69
Enterprise Value
 16.85B 11.71B 3.37B 4.21B 8.71B
EV to EBITDA
 40.16 27.91 11.08 -43.00 -18.69
EV to Sales
 12.22 8.49 3.43 5.87 16.31
EV to Free Cash Flow
 59.65 41.45 19.33 -20.70 -16.01
EV to Operating Cash Flow
 46.27 31.62 15.94 -54.91 -28.71
Tangible Book Value Per Share
 5.41 5.41 2.06 1.91 2.85
Shareholders’ Equity Per Share
 5.44 5.44 2.10 1.97 2.92
Tax and Other Ratios
Effective Tax Rate
 0.08 0.08 0.22 >-0.01 >-0.01
Revenue Per Share
 3.45 3.45 2.46 1.80 1.36
Net Income Per Share
 0.43 0.43 0.08 -0.96 -1.53
Tax Burden
 0.92 0.92 0.78 1.01 1.00
Interest Burden
 0.73 0.73 0.32 1.36 0.99
Research & Development to Revenue
 0.32 0.32 0.33 0.66 1.31
SG&A to Revenue
 0.29 0.29 0.32 0.40 0.49
Stock-Based Compensation to Revenue
 0.03 0.03 0.02 0.04 0.03
Income Quality
 1.94 1.97 4.92 0.20 0.50
Currency in CNY